Feline calicivirus

Veterinary Research

Volumn 38, Issue 2, 2007, Pages 319-335

  Radford, Alan D ^a   Coyne, Karen P ^a   Dawson, Susan ^a   Porter, Carol J ^a   Gaskell, Rosalind M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Calicivirus; Evolution; Feline; Vaccination; Virulence

Indexed keywords

ANTIBIOTIC AGENT; CYPROHEPTADINE; DIAZEPAM; INACTIVATED VACCINE; INTERFERON; JUNCTIONAL ADHESION MOLECULE A; LIVE VACCINE; VIRUS VACCINE;

ANIMAL LAMENESS; CALICIVIRUS; CAT; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; EPIDEMIOLOGICAL DATA; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTION CONTROL; INFECTION PREVENTION; MOUTH DISEASE; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PICORNAVIRUS INFECTION; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; SINGLE DRUG DOSE; SNEEZING; SYRUP; VACCINATION; VIRUS CARRIER; VIRUS GENOME; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; CALICIVIRIDAE INFECTIONS; CALICIVIRUS, FELINE; CAT DISEASES; CATS; VIRAL VACCINES;

ANIMALIA; CALICIVIRIDAE; FELIDAE; FELINE CALICIVIRUS; RNA VIRUSES;

EID: 34147142353     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1051/vetres:2006056     Document Type: Review

References (118)

1. Abd-Eldaim M., Potgieter L., Kennedy M., Genetic analysis of feline caliciviruses associated with a hemorrhagic-like disease, J. Vet. Diagn. Invest. (2005) 17:420-429.
2. Ando T., Noel J.S., Fankhauser R.L., Genetic classification of "Norwalk-like viruses", J. Infect. Dis. (2000) 181:S336-348.
3. Bannasch M.J., Foley J.E., Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters, J. Feline Med. Surg. (2005) 7:109-119.
4. Bennett D., Gaskell R.M., Mills A., Knowles J., Carter S., McArdle F., Detection of feline calicivirus antigens in the joints of infected cats, Vet. Rec. (1989) 124:329-332.
5. Binns S.H., Dawson S., Speakman A.J., Cuevas L.E., Hart C.A., Gaskell C.J., Morgan K.L., Gaskell R.M., A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus, J. Feline Med. Surg. (2000) 2:123-133.
6. Brunet S., Jas D., David F., Bublot M., Poulet H., Feline calicivirus: vaccinations against virulent strains, in: Comparative and emerging virus infections of dogs and cats, 2005, Liverpool.
7. Bull R.A., Hansman G.S., Clancy L.E., Tanaka M.M., Rawlinson W.D., White P.A., Norovirus recombination in ORF1/ORF2 overlap, Emerg. Infect. Dis. (2005) 11:1079-1085.
8. Cai Y., Fukushi H., Koyasu S., Kuroda E., Yamaguchi T., Hirai K., An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan, J. Vet. Med. Sci. (2002) 64:215-219.
9. Capucci L., Fusi P., Lavazza A., Pacciarini M.L., Rossi C., Detection and preliminary characterization of a new rabbit calicivirus related to rabbit hemorrhagic disease virus but nonpathogenic, J. Virol. (1996) 70:8614-8623.
10. Carter M.J., Milton I.D., Turner P.C., Meanger J., Bennett M., Gaskell R.M., Identification and sequence determination of the capsid protein gene of feline calicivirus, Arch. Virol. (1992) 122:223-235.
11. Chasey D., Rabbit haemorrhagic disease: the new scourge of Oryctolagus cuniculus, Lab. Anim. (1997) 31:33-44.
12. Clay S., Maherchandani S., Malik Y.S., Goyal S.M., Survival on uncommon fomites of feline calicivirus, a surrogate of noroviruses, Am. J. Infect. Control (2006) 34:41-43.
13. Coutts A.J., Dawson S., Willoughby K., Gaskell R.M., Isolation of feline respiratory viruses from clinically healthy cats at UK cat shows, Vet. Rec. (1994) 135:555-556.
14. Coyne K.P., Dawson S., Radford A.D., Cripps P.J., Porter C.J., McCracken C.M., Gaskell R.M., Long term analysis of feline calicivirus prevalence and viral shedding patterns in naturally infected colonies of domestic cats, Vet. Microbiol. (2006) 118:12-25.
15. Coyne K.P., Jones B.R., Kipar A., Chantrey J., Porter C.J., Barber P.J., Dawson S., Gaskell R.M., Radford A.D., Lethal outbreak of disease associated with feline calicivirus infection in cats, Vet. Rec. (2006) 158:544-550.
16. Coyne K.P., Reed F.C., Porter C.J., Dawson S., Gaskell R.M., Radford A.D., Recombination of feline calicivirus within an endemically infected cat colony, J. Gen. Virol. (2006) 87:921-926.
17. Dawson S., Smyth N.R., Bennett M., Gaskell R.M., McCracken C.M., Brown A., Gaskell C.J., Effect of primary-stage feline immunodeficiency virus infection on subsequent feline calicivirus vaccination and challenge in cats, AIDS (1991) 5:747-750.
18. Dawson S., McArdle F., Bennett D., Carter S.D., Bennett M., Ryvar R., Gaskell R.M., Investigation of vaccine reactions and breakdowns after feline calicivirus vaccination, Vet. Rec. (1993) 132:346-350.
19. Dawson S., McArdle F., Bennett M., Carter M., Milton I.P., Turner P., Meanger J., Gaskell R.M., Typing of feline calicivirus isolates from different clinical groups by virus neutralisation tests, Vet. Rec. (1993) 133:13-17.
20. Dawson S., Bennett D., Carter S.D., Bennett M., Meanger J., Turner P.C., Carter M.J., Milton I., Gaskell R.M., Acute arthritis of cats associated with feline calicivirus infection, Res. Vet. Sci. (1994) 56:133-143.
21. Dawson S., Willoughby K., Gaskell R.M., Wood G., Chalmers W.S., A field trial to assess the effect of vaccination against feline herpesvirus, feline calicivirus and feline panleucopenia virus in 6-week-old kittens, J. Feline Med. Surg. (2001) 3:17-22.
22. Domingo E., Menendez-Arias L., Holland J.J., RNA virus fitness, Rev. Med. Virol. (1997) 7:87-96.
23. Doultree J.C., Druce J.D., Birch C.J., Bowden D.S., Marshall J.A., Inactivation of feline calicivirus, a Norwalk virus surrogate, J. Hosp. Infect. (1999) 41:51-57.
24. Duizer E., Bijkerk P., Rockx B., De Groot A., Twisk F., Koopmans M., Inactivation of caliciviruses, Appl. Environ. Microbiol. (2004) 70:4538-4543.
25. Eleraky N.Z., Potgieter L.N., Kennedy M.A., Virucidal efficacy of four new disinfectants, J. Am. Anim. Hosp. Assoc. (2002) 38:231-234.
26. Ellis T.M., Jaundice in a siamese cat with in utero feline calicivirus infection, Aust. Vet. J. (1981) 57:383-385.
27. Fabricant C.G., Rich L.J., Microbial studies of feline urolithiasis, J. Am. Vet. Med. Assoc. (1971) 158:976-980.
28. Foley J., Hurley K., Pesavento P.A., Poland A., Pedersen N.C., Virulent systemic feline calicivirus infection: local cytokine modulation and contribution of viral mutants, J. Feline Med. Surg. (2006) 8:55-61.
29. Gandon S., Mackinnon M.J., Nee S., Read A.F., Imperfect vaccines and the evolution of pathogen virulence, Nature (2001) 414:751-756.
30. Gaskell R.M., Radford A.D., Dawson S., Feline infectious respiratory disease, in: Chandler E.A., Gaskell C.J., Gaskell R.M. (Eds.), Feline medicine and therapeutics, 2004, Blackwell Publishing, pp. 577-595.
31. Geissler K., Schneider K., Platzer G., Truyen B., Kaaden O.-R., Truyen U., Genetic and antigenic heterogeneity among feline calicivirus isolates from distinct disease manifestations, Virus Res. (1997) 48:193-206.
32. Geissler K., Schneider K., Truyen U., Mapping neutralizing and non-neutralizing epitopes on the capsid protein of feline calicivirus, J. Vet. Med. B Infect. Dis. Vet. Public Health (2002) 49:55-60.
33. Glenn M., Radford A.D., Turner P.C., Carter M., Lowery D., DeSilver D.A., Meanger J., Baulch-Brown C., Bennett M., Gaskell R.M., Nucleotide sequence of UK and Australian isolates of feline calicivirus (FCV) and phylogenetic analysis of FCVs, Vet. Microbiol. (1999) 67:175-193.
34. Green J., Vinje J., Gallimore C.I., Koopmans M., Hale A., Brown D.W., Clegg J.C., Chamberlain J., Capsid protein diversity among Norwalk-like viruses, Virus Genes (2000) 20:227-236.
35. Green K.Y., Ando T., Balayan M.S., Berke T., Clarke I.N., Estes M.K., Matson D.O., Nakata S., Neill J.D., Studdert M.J., Thiel H.J., Taxonomy of the caliciviruses, J. Infect. Dis. (2000) 181:S322-S330.
36. Harbour D.A., Howard P.E., Gaskell R.M., Isolation of feline calicivirus and feline herpesvirus from domestic cats 1980 to 1989, Vet. Rec. (1991) 128:77-80.
37. Harley R., Helps C.R., Harbour D.A., Gruffydd-Jones T.J., Day M.J., Cytokine mRNA expression in lesions in cats with chronic gingivostomatitis, Clin. Diagn. Lab. Immunol. (1999) 6:471-478.
38. Harrington P.R., Vinje J., Moe C.L., Baric R.S., Norovirus capture with histo-blood group antigens reveals novel virus-ligand interactions, J. Virol. (2004) 78:3035-3045.
39. Hashimoto M., Roerink F., Tohya Y., Mochizuki M., Genetic analysis of the RNA polymerase gene of caliciviruses from dogs and cats, J. Vet. Med. Sci. (1999) 61:603-608.
40. Helps C.R., Lait P., Damhuis A., Bjornehammar U., Bolta D., Brovida C., Chabanne L., Egberink H., Ferrand G., Fontbonne A., Pennisi M.G., Gruffydd-Jones T., Gunn-Moore D., Hartmann K., Lutz H., Malandain E., Mostl K., Stengel C., Harbour D.A., Graat E.A., Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries, Vet. Rec. (2005) 156:669-673.
41. Holst B.S., Berndtsson L.T., Englund L., Isolation of feline herpesvirus-1 and feline calicivirus from healthy cats in Swedish breeding catteries, J. Feline Med. Surg. (2005) 7:325-331.
42. Hurley K.E., Pesavento P.A., Pedersen N.C., Poland A.M., Wilson E., Foley J.E., An outbreak of virulent systemic feline calicivirus disease, J. Am. Vet. Med. Assoc. (2004) 224:241-249.
43. Hurley K.F., Sykes J.E., Update on feline calicivirus: new trends, Vet. Clin. North Am. Small Anim. Pract. (2003) 33:759-772.
44. Hutson A.M., Atmar R.L., Marcus D.M., Estes M.K., Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens, J. Virol. (2003) 77:405-415.
45. Iglauer F., Gartner K., Morstedt R., Maternal protection against feline respiratory disease by means of booster vaccinations during pregnancy - a retrospective clinical study, Kleintierpraxis (1989) 34:235.
46. Jiang X., Espul C., Zhong W.M., Cuello H., Matson D.O., Characterization of a novel human calicivirus that may be a naturally occurring recombinant, Arch. Virol. (1999) 144:2377-2387.
47. Johnson R.P., Povey R.C., Transfer and decline of maternal antibody to feline calicivirus, Can. Vet. J. (1983) 24:6-9.
48. Johnson R.P., Antigenic change in feline calicivirus during persistent infection, Can. J. Vet. Res. (1992) 56:326-330.
49. Kahn D.E., Gillespie J.H., Feline viruses: Pathogenesis of picornavirus infection in the cat, Am. J. Vet. Res. (1971) 32:521-531.
50. Katayama K., Miyoshi T., Uchino K., Oka T., Tanaka T., Takeda N., Hansman G.S., Novel recombinant sapovirus, Emerg. Infect. Dis. (2004) 10:1874-1876.
51. Knowles J.O., Studies on feline calicivirus with particular reference to chronic stomatitis in the cat, 1988, University of Liverpool.
52. Knowles J.O., Gaskell R.M., Gaskell C.J., Harvey C.E., Lutz H., Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis, Vet. Rec. (1989) 124:336-338.
53. Knowles J.O., McArdle F., Dawson S., Carter S.D., Gaskell C.J., Gaskell R.M., Studies on the role of feline calicivirus in chronic stomatitis in cats, Vet. Microbiol. (1991) 27:205-219.
54. Kreutz L.C., Johnson R.P., Seal B.S., Phenotypic and genotypic variation of feline calicivirus during persistent infection of cats, Vet. Microbiol. (1998) 59:229-236.
55. Lappin M.R., Sebring R.W., Porter M., Radecki S.J., Veir J., Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1, J. Feline Med. Surg. (2006) 8:158-163.
56. Lauritzen A., Jarrett O., Sabara M., Serological analysis of feline calicivirus isolates from the United States and United Kingdom, Vet. Microbiol. (1997) 56:55-63.
57. Lindesmith L., Moe C., Marionneau S., Ruvoen N., Jiang X., Lindblad L., Stewart P., LePendu J., Baric R., Human susceptibility and resistance to Norwalk virus infection, Nat. Med. (2003) 9:548-553.
58. Liu S.J., Xue H.P., Pu B.Q., Qian N.H., A new viral disease in rabbits, Animal Husbandry and Veterinary Medicine (1984) 16:253-255.
59. Lommer M.J., Verstraete F.J., Concurrent oral shedding of feline calicivirus and feline herpesvirus 1 in cats with chronic gingivostomatitis, Oral Microbiol. Immunol. (2003) 18:131-134.
60. Love D.N., Baker K.D., Sudden death in kittens associated with a feline picornavirus, Aust. Vet. J. (1972) 48:643.
61. Mackinnon M.J., Read A.F., Virulence in malaria: an evolutionary viewpoint, Philos. Trans. R Soc. Lond. B Biol. Sci. (2004) 359:965-986.
62. Makino A., Shimojima M., Miyazawa T., Kato K., Tohya Y., Akashi H., Junctional adhesion molecule 1 is a functional receptor for feline calicivirus, J. Virol. (2006) 80:4482-4490.
63. Marks P.J., Vipond I.B., Carlisle D., Deakin D., Fey R.E., Caul E.O., Evidence for airborne transmission of Norwalk-like virus (NLV) in a hotel restaurant, Epidemiol. Infect. (2000) 124:481-487.
64. Martella V., Pratelli A., Gentile M., Buonavoglia D., Decaro N., Fiorente P., Buonavoglia C., Analysis of the capsid protein gene of a feline-like calicivirus isolated from a dog, Vet. Microbiol. (2002) 85:315-322.
65. McArdle F., Dawson S., Carter M.J., Milton I.D., Turner P.C., Meanger J., Bennett M., Gaskell R.M., Feline calicivirus strain differentiation using monoclonal antibody analysis in an enzyme-linked immunoflow-assay, Vet. Microbiol. (1996) 51:197-206.
66. McCabe V.J., Tarpey I., Spibey N., Vaccination of cats with an attenuated recombinant myxoma virus expressing feline calicivirus capsid protein, Vaccine (2002) 20:2454-2462.
67. McCabe V.J., Spibey N., Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein, Vaccine (2005) 23:5380-5388.
68. Mochizuki M., Kawakami K., Hashimoto M., Ishida T., Recent epidemiological status of feline upper respiratory infections in Japan, J. Vet. Med. Sci. (2000) 62:801-803.
69. Morrison W.B., Starr R.M., Vaccine-associated feline sarcomas, J. Am. Vet. Med. Assoc. (2001) 218:697-702.
70. Nagesha H.S., McColl K.A., Collins B.J., Morrissy C.J., Wang L.F., Westbury H.A., The presence of cross-reactive antibodies to rabbit haemorrhagic disease virus in Australian wild rabbits prior to the escape of virus from quarantine, Arch. Virol. (2000) 145:749-757.
71. Natoni A., Kass G.E., Carter M.J., Roberts L.O., The mitochondrial pathway of apoptosis is triggered during feline calicivirus infection, J. Gen. Virol. (2006) 87:357-361.
72. Ohlinger V.F., Haas B., Meyers G., Weiland F., Thiel H.J., Identification and characterization of the virus causing rabbit hemorrhagic disease, J. Virol. (1990) 64:3331-3336.
73. Oliver S.L., Brown D.W., Green J., Bridger J.C., A chimeric bovine enteric calicivirus: evidence for genomic recombination in genogroup III of the Norovirus genus of the Caliciviridae, Virology (2004) 326:231-239.
74. Orr C.M., Gaskell C.J., Gaskell R.M., Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state, Vet. Rec. (1980) 106:164-166.
75. Pedersen N.C., Laliberte L., Ekman S., A transient febrile limping syndrome of kittens caused by two different strains of feline calicivirus, Feline Pract. (1983) 13:26-35.
76. Pedersen N.C., Hawkins K.F., Mechanisms of persistence of acute and chronic feline calicivirus infections in the face of vaccination, Vet. Microbiol. (1995) 47:141-156.
77. Pedersen N.C., Elliott J.B., Glasgow A., Poland A., Keel K., An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus, Vet. Microbiol. (2000) 73:281-300.
78. Pesavento P.A., MacLachlan N.J., Dillard-Telm L., Grant C.K., Hurley K.F., Pathologic, immunohistochemical, and electron microscopic findings in naturally occurring virulent systemic feline calicivirus infection in cats, Vet. Pathol. (2004) 41:257-263.
79. Poulet H., Brunet S., Soulier M., Leroy V., Goutebroze S., Chappuis G., Comparison between acute oral/respiratory and chronic stomatitis/gingivitis isolates of feline calicivirus: pathogenicity, antigenic profile and cross-neutralisation studies, Arch. Virol. (2000) 145:243-261.
80. Poulet H., Brunet S., Leroy V., Chappuis G., Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges, Vet. Microbiol. (2005) 106:17-31.
81. Povey C., Ingersoll J., Cross-protection among feline caliciviruses, Infect. Immun. (1975) 11:877-885.
82. Povey R.C., Serological relationships among feline caliciviruses, Infect. Immun. (1974) 10:1307-1314.
83. Povey R.C., Effect of orally administered ribavirin on experimental feline calicivirus infection in cats, Am. J. Vet. Res. (1978) 39:1337-1341.
84. Radford A.D., Bennett M., McArdle F., Dawson S., Turner P.C., Glenn M.A., Gaskell R.M., The use of sequence analysis of a feline calicivirus (FCV) hypervariable region in the epidemiological investigation of FCV related disease and vaccine failures, Vaccine (1997) 15:1451-1458.
85. Radford A.D., Turner P.C., Bennett M., McArdle F., Dawson S., Glenn M.A., Williams R.A., Gaskell R.M., Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats, J. Gen. Virol. (1998) 79:1-10.
86. Radford A.D., Willoughby K., Dawson S., McCracken C., Gaskell R.M., The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions, J. Virol. (1999) 73:8496-8502.
87. Radford A.D., Dawson S., Wharmby C., Ryvar R., Gaskell R.M., Comparison of serological and sequence-based methods for typing feline calicivirus isolates from vaccine failures, Vet. Rec. (2000) 146:117-123.
88. Radford A.D., Sommerville L.M., Dawson S., Kerins A.M., Ryvar R., Gaskell R.M., Molecular analysis of isolates of feline calicivirus from a population of cats in a rescue shelter, Vet. Rec. (2001) 149:477-481.
89. Radford A.D., Sommerville L., Ryvar R., Cox M.B., Johnson D.R., Dawson S., Gaskell R.M., Endemic infection of a cat colony with a feline calicivirus closely related to an isolate used in live attenuated vaccines, Vaccine (2001) 19:4358-4362.
90. Radford A.D., Dawson S., Ryvar R., Coyne K., Johnson D.R., Cox M.B., Acke E.F., Addie D.D., Gaskell R.M., High genetic diversity of the immunodominant region of the feline calicivirus capsid gene in endemically infected cat colonies, Virus Genes (2003) 27:145-155.
91. Reubel G.H., Hoffmann D.E., Pedersen N.C., Acute and chronic faucitis of domestic cats: a feline calicivirus induced disease, Vet. Clin. North Am. Small Anim. Pract. (1992) 22:1347-1360.
92. Rice C.C., Kruger J.M., Venta P.J., Vilnis A., Maas K.A., Dulin J.A., Maes R.K., Genetic characterization of 2 novel feline caliciviruses isolated from cats with idiopathic lower urinary tract disease, J. Vet. Intern. Med. (2002) 16:293-302.
93. Roerink F., Hashimoto M., Tohya Y., Mochizuki M., Genetic analysis of a canine calicivirus: evidence for a new clade of animal caliciviruses, Vet. Microbiol. (1999) 69:69-72.
94. Sato Y., Ohe K., Murakami M., Fukuyama M., Furuhata K., Kishikawa S., Suzuki Y., Kiuchi A., Hara M., Ishikawa Y., Taneno A., Phylogenetic analysis of field isolates of feline calicivirus (FCV) in Japan by sequencing part of its capsid gene, Vet. Res. Commun. (2002) 26:205-219.
95. Schorr-Evans E.M., Poland A., Pedersen N.C., An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England, J. Feline Med. Surg. (2003) 5:217-226.
96. Scott F.W., Virucidal disinfectants and feline viruses, Am. J. Vet. Res. (1980) 41:410-414.
97. Scott F.W., Geissinger C.M., Duration of immunity in cats vaccinated with an inactivated feline panleukopenia, herpesvirus and calicivirus vaccine, Feline Pract. (1997) 25:12-19.
98. Scott F.W., Geissinger C.M., Long-term immunity in cats vaccinated with an inactivated trivalent vaccine, Am. J. Vet. Res. (1999) 60:652-658.
99. Seal B.S., Ridpath J.F., Mengeling W.L., Analysis of feline calicivirus capsid protein genes: identification of variable antigenic determinant regions of the protein, J. Gen. Virol. (1993) 74:2519-2524.
100. Sommerville L.M., Radford A.D., Glenn M., Dawson S., Gaskell C.J., Kelly D.F., Cripps P.J., Porter C.J., Gaskell R.M., DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein, Vaccine (2002) 20:1787-1796.
101. Sosnovtsev S., Green K.Y., RNA transcripts derived from a cloned full-length copy of feline calicivirus genome do not require VpG for infectivity, Virology (1995) 210:383-390.
102. Sosnovtsev S.V., Sosnovtseva S.A., Green K.Y., Cleavage of the feline calicivirus capsid precursor is mediated by a virus-encoded proteinase, J. Virol. (1998) 72:3051-3059.
103. Sosnovtsev S.V., Green K.Y., Identification and genomic mapping of the ORF3 and VPg proteins in feline calicivirus virions, Virology (2000) 277:193-203.
104. Sosnovtsev S.V., Prikhod'ko E.A., Belliot G., Cohen J.I., Green K.Y., Feline calicivirus replication induces apoptosis in cultured cells, Virus Res. (2003) 94:1-10.
105. Sykes J.E., Studdert V.P., Browning G.F., Detection and strain differentiation of feline calicivirus in conjunctival swabs by RT-PCR of the hypervariable region of the capsid protein gene, Arch. Virol. (1998) 143:1321-1334.
106. Taira O., Suzuki M., Takeuchi Y., Aramaki Y., Sakurai I., Watanabe T., Motokawa K., Arai S., Sato H., Maehara N., Expression of feline interferon-alpha subtypes in Escherichia coli, and their antiviral activity and animal species specificity, J. Vet. Med. Sci. (2005) 67:543-545.
107. Tenorio A.P., Franti C.E., Madewell B.R., Pedersen N.C., Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses, Vet. Immunol. Immunopathol. (1991) 29:1-14.
108. TerWee T., Lauritzen A., Sabara M., Dreier K.J., Kokjohn K., Comparison of the primary signs induced by experimental exposure to either a pneumotrophic or a "limping" strain of feline calicivirus, Vet. Microbiol. (1997) 56:33-45.
109. Thompson R.R., Wilcox G.E., Clark W.T., Jansen K.L., Association of calicivirus infection with chronic gingivitis and pharyngitis in cats, J. Small Anim. Pract. (1984) 25:207-210.
110. Tohya Y., Yokoyama N., Maeda K., Kawaguchi Y., Mikami T., Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus, J. Gen. Virol. (1997) 78:303-305.
111. Umehashi M., Imamura T., Akiyama S., Kimachi K., Tokiyoshi S., Mikami T., Post-exposure treatment of cats with mousecat chimeric antibodies against feline herpesvirus type 1 and feline calicivirus, J. Vet. Med. Sci. (2002) 64:1017-21.
112. Umehashi M., Imamura T., Akiyama S., Matsuda J., Tokiyoshi S., Tohya Y., Mikami T., Pre-exposure treatment of cats with anti-FHV-1 and anti-FCV mouse-cat chimeric antibodies, J. Vet. Med. Sci. (2003) 65:563-566.
113. Wardley R.C., Gaskell R.M., Povey R.C., Feline respiratory viruses - their prevalence in clinically healthy cats, J. Small Anim. Pract. (1974) 15:579-586.
114. Wardley R.C., Feline calicivirus carrier state: A study of the host/virus relationship, Arch. Virol. (1976) 52:243-249.
115. Wardley R.C., Povey R.C., The clinical disease and patterns of excretion associated with three different strains of feline calicivirus, Res. Vet. Sci. (1977) 23:7-14.
116. Waters L., Hopper C.D., Gruffydd-Jones T.J., Harbour D.A., Chronic gingivitis in a colony of cats infected with feline immunodeficiency virus and feline calicivirus, Vet. Rec. (1993) 132:340-342.
117. Willcocks M.M., Carter M.J., Roberts L.O., Cleavage of eukaryotic initiation factor eIF4G and inhibition of host-cell protein synthesis during feline calicivirus infection, J. Gen. Virol. (2004) 85:1125-30.
118. Yokoyama N., Fujita K., Damiani A., Sato E., Kurosawa K., Miyazawa T., Ishiguro S., Mochizuki M., Maeda K., Mikami T., Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen, J. Vet. Med. Sci. (1998) 60:717-723.